It was shown that ubiquitin conjugating enzyme E2T (UBE2T) exhibits oncogenic properties [259] while genetic ablation of Ube2o (ubiquitin conjugating enzyme E2O) impairs progression of prostate cancer. The gene discussed is UBE2T; the disease is prostate cancer.